Therefore, we hypothesize that chromosome 21-driven over-expression of the anti-angiogenic factors, COL18A1, APP and DSCR1, individually or in combination, play a previously unidentified role in disrupting lung vascular development and contribute to the pathobiology of lung hypoplasia and risk for PAH in subjects with DS. Here, COL18A1 is linked to Dravet syndrome.